Skip to main content
Download PDF

Toxoplasma gondii infection regulates apoptosis of host cells via miR-185/ARAF axis

Parasites & Vectors volume 16, Article number: 371 (2023) Cite this article

Abstract

Background

Toxoplasmosis is a zoonosis with a worldwide presence that is caused by the intracellular parasite Toxoplasma gondii. Active regulation of apoptosis is an important immune mechanism by which host cells resist the growth of T. gondii or avoid excessive pathological damage induced by this parasite. Previous studies found that upregulated expression of microRNA-185 (miR-185) during T. gondii infection has a potential role in regulating the expression of the ARAF gene, which is reported to be associated with cell proliferation and apoptosis.

Methods

The expression levels of miR-185 and the ARAF gene were evaluated by qPCR and Western blot, respectively, in mice tissues, porcine kidney epithelial cells (PK-15) and porcine alveolar macrophages (3D4/21) following infection with the T. gondii ToxoDB#9 and RH strains. The dual luciferase reporter assay was then used to verify the relationship between miR-185 and ARAF targets in PK-15 cells. PK-15 and 3D4/21 cell lines with stable knockout of the ARAF gene were established by CRISPR, and then the apoptosis rates of the cells following T. gondii infection were detected using cell flow cytometry assays. Simultaneously, the activities of cleaved caspase-3, as a key apoptosis executive protein, were detected by Western blot to evaluate the apoptosis levels of cells.

Results

Infection with both the T. gondii ToxoDB#9 and RH strains induced an increased expression of miR-185 and a decreased expression of ARAF in mice tissues, PK-15 and 3D4/21 cells. MiR-185 mimic transfections showed a significantly negative correlation in expression levels between miR-185 and the ARAF gene. The dual luciferase reporter assay confirmed that ARAF was a target of miR-185. Functional investigation revealed that T. gondii infection induced the apoptosis of PK-15 and 3D4/21 cells, which could be inhibited by ARAF knockout or overexpression of miR-185. The expression levels of cleaved caspase-3 protein were significantly lower in cells with ARAF knockout than in normal cells, which were consistent with the results of the cell flow cytometry assays.

Conclusions

Toxoplasma gondii infection could lead to the upregulation of miR-185 and the downregulation of ARAF, which was not related to the strain of T. gondii and the host cells. Toxoplasma gondii infection could regulate the apoptosis of host cells via the miR-185/ARAF axis, which represents an additional strategy used by T. gondii to counteract host-cell apoptosis in order to maintain survival and reproduce in the host cells.

Graphical Abstract

Background

Toxoplasma gondii is an obligate intracellular parasitic protozoan belonging to the phylum Apicomplexa. The parasite is globally distributed and has been described to infect virtually all warm-blooded species including humans. Infection with the parasite occurs through the ingestion of food and water contaminated with oocysts shed in feces of infected cats or the consumption of raw and undercooked meat containing tissue cysts, or by the transplacental transmission of tachyzoites from mother to unborn child [1,2,3,4]. Toxoplasma gondii infection is usually asymptomatic in healthy individuals, but in immunodeficient individuals, such as unborn fetuses or patients with acquired immune deficiency syndrome (AIDS), T. gondii infection may cause symptomatic disease, including encephalitis, retinochoroiditis, foetus abortion, splenomegaly and pneumonitis [5, 6]. Toxoplasma gondii infection can also cause severe damage to livestock, inducing the acute onset of toxoplasmosis and death in pigs and abortion in sheep [1, 7]. Variation in clinical presentation and severity of disease might be attributed to the genetic heterogeneity of the host and the genotype of the infective parasite [4,5,6], but it remains poorly understood just how different T. gondii strains influence disease. The mechanisms by which T. gondii persists are poorly studied in pigs.

MicroRNAs (miRNAs) are 18- to 22-nucleotide-long non-coding RNAs that act on post-transcriptional gene regulation, causing degradation of messenger RNA (mRNA) or inhibiting its translation into proteins [8, 9]. miRNAs influence many cellular processes, including cell proliferation, differentiation, migration, apoptosis and angiogenesis, as well as carcinogenesis [9]. Toxoplasma gondii infection dysregulates the expression of specific host miRNAs, which contributes to efficient parasite replication by altering the signalling pathways involved in the defensive response of infected cells [10,11,12,13]. In our previous studies, we found that the atypical genotype Chinese I (ToxoDB#9) strain can cause acute disease in piglets and alterations in miRNA expression profiles in spleen and brain tissues, with the expression of miR-185 identified as being upregulated [14, 15].

MiR-185 is located at chromosome 22q11.21 and is haplo-insufficient in patients with 22q11.2/DiGeorge syndrome [16] who can have thymic hypoplasia, hypoparathyroidism, cardiac anomalies and/or learning disabilities [17]. Dysregulation of miR-185 mainly occurs in various pathological states, especially in human cancers. The majority of experimental data indicates that miR-185 exhibits tumour-suppressive activities by affecting many critical biological processes, such as the cell cycle, epithelial-to-mesenchymal transition, apoptosis, autophagy, invasion and metastasis [18]. In addition, miR-185 plays a crucial role in regulating bone formation and remodelling. MiR-185-5p serves as an important regulator of amelogenesis and osteoblast differentiation and may contribute to ameloporosis [19, 20]. miR-185 targets multiple genes or pathways to execute its function [18]. In our previous studies, bioinformatics analysis revealed that the A-rapidly accelerated fibrosarcoma (ARAF) gene was a target of miR-185 [14, 15].

ARAF is a serine/threonine protein kinase and a member of the Raf family protein kinases, which consist of the ARAF, BRAF and CRAF isoforms [21]; these kinases regulate a variety of basic cellular functions including proliferation, differentiation, transformation, apoptosis and metabolism, mainly through the MEK/ERK pathway [22]. In comparison with BRAF and CRAF, ARAF has the lowest basal kinase activity for activating MEK [23], with the maximal activity of ARAF being only 20% of that of CRAF [21]. ARAF is considered to be a crucial signaling hub controlling cellular processes such as proliferation, apoptosis and glucose metabolism [24]. A previous study showed that 27 and 15 out of 132 proteins interacting with ARAF were involved in apoptosis and apoptosis signal transduction, respectively [25]. ARAF has also been demonstrated to play an important role in several tumours and diseases [21]. However, to date, the role of ARAF during T. gondii infection has not been reported.

The aim of the present study was to confirm the regulation of miR-185 on ARAF expression and the role of the miR-185/ARAF axis in modulating host cell apoptosis during T. gondii infection. Our study will provide novel insights into the role of miR-185 in the host response to T. gondii infection, and will further deepen our understanding of the interactions between the host and T. gondii.

Methods

Toxoplasma gondii strains, cells and animals

The T. gondii YZ-1 strain, isolated from a home-bred wild boar in Jiangsu Province of China, was identified as ToxoDB #9 (Chinese I genotype), the most prevalent genotype in China, and shown to be virulent in mice in our previous study [26]. Toxoplasma gondii RH strain, an international standard virulent strain, was provided by Yonghua Zhou from the Jiangsu Institute of Parasitic Diseases (Wuxi, China) and maintained in our laboratory.

The PK-15 cell line was purchased from Shanghai Zhong Qiao Xin Zhou Biotechnology Co., Ltd (Shanghai, China). The cells were cultured at 37 °C with 5% CO2 in DMEM medium (Gibco, Shanghai, China) with 10% fetal bovine serum (FBS; Eallbio, Beijing, China) containing 100 IU/ml penicillin and 100 μg/ml streptomycin (Beyotime, Shanghai, China). The 3D4/21 cell line was maintained in our laboratory. The cells were cultured at 37 °C with 5% CO2 in RPMI 1640 medium (Gibco) with 10% FBS containing 100 IU/ml penicillin and 100 μg/ml streptomycin.

Specific pathogen-free (SPF) ICR mice, each weighing 22 ± 2 g, were purchased from the Comparative Medicine Center of Yangzhou University (Yangzhou, China). Mice were given free access to granulated food and water. All mice were treated in strict accordance with the recommendations of the guide for the conduct of studies with experimental animals of the People’s Republic of China. The study protocol was approved by the Animal Care and Use Committee of the College of Veterinary Medicine, Yangzhou University (Approval ID: SYXK [Su] 2012-0029).

Vectors, primers and miRNA

The psiCHECK2 luciferase reporter vector was purchased from General Biol (Anhui, China). LentiCRISPRv2 plasmid was generously provided by Prof. Ye J (The College of Veterinary Medicine, Yangzhou University, Yangzhou, China). The pcDNA3.1-3xflag-C vector was purchased from Bast Biology (Nanjing, China). All primers (Table 1) were synthesised by Tsingke Biotechnology (Beijing, China). The miR-185 mimic and mimic control were synthesised by Suzhou Genepharma Co., Ltd (Suzhou, China), of which the miR-185 mimic was predicted to target the ARAF gene, and the mimic control was a random sequence that has no homology with any mammalian sequence (Table 1).

Table 1 Sequences of microRNA and primers used in the experiment
Full size table

Quantitative real-time PCR

Total RNA was isolated from PK-15 cells, 3D4/21 cells and mouse viscera using the FastPure Cell/Tissue Total RNA Isolation Kit V2 (Vazyme, Nanjing, China) according to the manufacturer’s protocol. The mRNA was reverse transcribed using the HiScript III RT SuperMix for qPCR Kit (Vazyme) and Mir-X miRNA First-Strand Synthesis Kit (Takara, Beijing, China) according to the respective manufacturer’s protocol. Quantitative real-time PCR (qPCR) reactions were performed using the AceQ Universal SYBR qPCR Master Mix (Vazyme) in a 20-μl reaction mixture; each reaction was performed in triplicate. The expression levels of the ARAF gene were quantified and normalised to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using the 2−ΔΔCt method, and the expression levels of miR-185 were quantified and normalised to U6 (Takara) using the 2−ΔΔCt method.

Western blot

Cellular proteins from PK-15 and 3D4/21 cells were extracted using RIPA Lysis Buffer (Takara) supplemented with proteinase inhibitor cocktail (Beyotime). The protein concentrations were determined using the BCA Protein Assay Kit (Beyotime). Equal amounts of proteins were subjected to 10–15% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE), and the products subsequently transferred onto nitrocellulose membranes. The membranes were then blocked with nonfat milk for 2 h, incubated with the primary antibody overnight at 4 °C and then washed twice with TBST, following which the membranes were incubated with the secondary antibodies for 1 h at room temperature. To detect ARAF, its epitopes were detected using rat anti-ARAF antibody (Abcam, Wuhan, China) at a 1:1 000 dilution followed by secondary probing with HRP Goat Anti-Rabbit IgG (H + L) (ABclonal, Wuhan, China) at a 1:10 000 dilution. To detect cleaved-caspase-3, its epitopes were detected using rat anti-cleaved-caspase-3 antibody (ImmunoWay, SuZhou, China) at a 1:1000 dilution, followed by secondary probing with HRP Goat Anti-Rabbit IgG (H + L) at a 1:10,000 dilution. Protein bands were detected using the ECL Detection Kit (Tanon, Beijing, China) and imaged.

To ensure equal loading of samples, we also probed with anti-GAPDH Mouse monoclonal antibody (mAb; ABclonal) at a 1:5000 dilution followed by HRP Goat Anti-Mouse IgG (ABclonal) at a 1:10,000 dilution.

Detection of expression level of miR-185 and ARAF after T. gondii infection

Experiment in vivo

Nine mice were randomly assigned to three groups of three mice each. The mice were intraperitoneally infected with 200 tachyzoites of T. gondii RH strain or 2000 tachyzoites of T. gondii YZ-1 strain, respectively. At 10 days post-challenge, the mice were sacrificed and their liver, spleen, heart, lung and kidney tissues were separately removed. Total RNA and proteins were extracted from each of these tissues using the FastPure Cell/Tissue Total RNA Isolation Kit V2 (Vazyme). The expression levels of miR-185 and ARAF gene were detected by qPCR. The uninfected mouse tissues served as the negative control.

Experiment in vitro

PK-15 and 3D4/21 cells were plated in 6-well plates 1 day in advance of the experiment. When the cell density had increased to 60%–80%, PK-15 and 3D4/21 cells were inoculated with tachyzoites of T. gondii YZ-1 strain or T. gondii RH strain, respectively, at a parasite to cell ratio of 5:1. At 6 h after inoculation, the medium was changed to DMEM or DMEM/1640 containing 2% FBS. At 24 h of infection, the cells were collected for RNA and protein extraction. The expression levels of miR-185 and ARAF gene were detected by qPCR and Western blot, respectively. The groups without inoculation were used as blank controls. The test was repeated three times.

Detection of expression level of miR-185 and ARAF after miRNA transfection

PK-15 and 3D4/21 cells were plated in 6-well plates 1 day in advance of the experiment. When the cell density had increased to 60–80%, cells were transfected in accordance with the guidelines of Lipofectamine RNAiMAX (Invitrogen Shanghai, China). Briefly, a total of 150 µl non-serum-supplemented Opti-MEN (Invitrogen) was used to dilute 9 µl Lipofectamine RNAiMAX or 100 pmol miR-185 mimics (the final concentration: 50 nM), respectively. Then the two types of liquid were mixed, incubated at room temperature for 5 min and then placed into culture plates. After culture at 37 °C with 5% CO2 for 8 h, the cells were transferred into complete medium for 24 h and then collected for detecting the expression levels of miR-185 and ARAF by qPCR and Western blot. The cells transfected with mimic control were used as the blank control. The test was repeated three times.

Dual-luciferase reporter assay

The relationship between ARAF and miR-185 was verified by the dual luciferase reporter gene assay. Briefly, the potential binding sites of MiR-185 to ARAF was predicted by RNAhybrid software (https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid). The original fragment of ARAF was cloned with primer PsiCHECK2 (XhoI)-ARAF-F-P1 and PsiCHECK2 (NotI)-Aarf-F-P4. ARAF-M-R-P2 and ARAF-M-R-P3 primers containing mutation sites were designed as described by Ho et al. [27], and then the fragment of ARAF containing the mutated site was amplified and sequenced. The original fragment and mutation fragment were cloned to the luciferase gene downstream of psiCHECK2. The recombinant vectors were named psiCHECK2-ARAF WT and psiCHECK2-ARAF MUT, respectively, and used for the experiment in PK-15 cells. In this experiment, the cells were divided into three groups: NC (cells transfected with psiCHECK2), ARAF WT (cells transfected with psiCHECK2-ARAF WT), and ARAF MUT (cells transfected with psiCHECK2-ARAF MUT), and each group was co-transfected with miR-185 mimic or mimic control, respectively. Cells were co-transfected with vectors and miR-185 mimic or mimic control using Lipofectamine 3000 (Invitrogen) and then cultured as described above. Finally, Firefly and Renilla luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega, Beijing, China) according to the manufacturer’s instructions. The test was repeated three times.

Detection of apoptosis in cells transfected with miR-185 mimic and infected with T. gondii

To investigate the roles of miR-185 in regulating apoptosis during T. gondii infection, PK-15 and 3D4/21 cells were each divided into four groups: (i) a group transfected with miR-185 mimic/T. gondii infection; (ii) a group transfected with miR-185 mimic/without T. gondii infection; (iii) a group transfected with miR-185 mimic control/T. gondii infection; and (iv) a group transfected with miR-185 mimic control/without T. gondii infection. Cells were transfected with miRNA by Lipofectamine RNAiMAX and were inoculated with T. gondii YZ-1 strain as described above. At 24 h after inoculation, the cells were harvested and stained by the Annexin V-FITC/PI Apoptosis Detection Kit (Vazyme), and apoptosis was evaluated using a CytoFLEX Flow Cytometer (Beckman, Shanghai, China). The protein expression levels of cleaved caspase-3 (CL-caspase3), which is a key pro-apoptotic protein involved in the execution phase of multiple apoptotic pathways, was detected by Western blot.

Establishment of cell lines with stable knockout of the ARAF gene

According to the sequence of the ARAF gene, the single guide RNA (sgRNA) was designed by CHOPCHOP software (http://chopchop.cbu.uib.no/), and a pair of primers named sgRNA-F and sgRNA-R (Table1) were synthesised. According to the manufacturer’s instructions, the sgRNA was annealed to form double-stranded DNA and then cloned into the lentiCRISPRv2 vector and named lentiCRISPRv2-KOARAF. PK-15 and 3D4/21 cells were transfected with lentiCRISPRv2-KOARAF plasmid using Lipofectamine 3000 as described above, and selected by puromycin. The cell lines (named PK-15-KOARAF and 3D4/21-KOARAF cells) with stable knockout of the ARAF gene were selected by subcloning, and ARAF knockout was verified by qPCR, Western blot and sequencing.

Construction of ARAF overexpression vector

The overexpression vector of ARAF was constructed as previously described [28]. Briefly, the full-length coding sequences (CDS) of ARAF were amplified by PCR with primers ARAF-F and ARAF-R (Table 1). PCR products were ligated into pcDNA3.1-3xflag-C vector. The vector containing the full-length CDS was named pcDNA3.1-Flag-ARAF; the vector without the ARAF fragment was named pcDNA3.1-Flag. As described above, the recombinant vector pcDNA3.1-Flag-ARAF was transfected into PK-15, PK-15-KOARAF, 3D4/21 and 3D4/21-KOARAF cells, and 24 h after transfection, the efficiency of ARAF overexpression was evaluated by Western blot. The cells transfected with pcDNA3.1-Flag were used as blank controls. The test was repeated three times.

Detection of apoptosis in ARAF knockout cells infected with T. gondii

To explore whether ARAF is involved in regulating apoptosis during T. gondii infection, apoptosis rates and protein expression levels of cleaved caspase-3 were detected in PK-15, PK-15-KOARAF, 3D4/21 and 3D4/21-KOARAF cells, respectively. Briefly, each cell line was divided into two groups: (i) a group with T. gondii infection; and (ii) a group without T. gondii infection. The cells were inoculated with T. gondii YZ-1 strain as described above. At 24 h after inoculation, the cells were harvested and used to detect the levels of apoptosis and cleaved caspase-3 expression as described above. The test was repeated three times.

In order to further confirm that T. gondii infection regulate apoptosis of host cells through a miR-185-ARAF axis, the complementation test was performed in both PK-15-KOARAF and 3D4/21-KOARAF cells using ARAF overexpression vector. Briefly, each cell line was divided into four groups: (i) a group transfected with pcDNA3.1-Flag-ARAF/T. gondii infection; (ii) a group transfected with pcDNA3.1-Flag-ARAF/without T. gondii infection; (iii) a group transfected with pcDNA3.1-Flag/T. gondii infection; and (iv) a group transfected with pcDNA3.1-Flag/without T. gondii infection. The cells were transfected with vector and inoculated with T. gondii YZ-1 strain as described above. At 24 h after inoculation, the cells were harvested and used to detect the levels of apoptosis and cleaved caspase-3 expression as described above. The test was repeated three times.

Statistical analysis

All statistical data presented are representative of ≥ 3 independent experiments and presented as the mean ± standard deviation (SD). Comparisons between two groups were analysed using the t-test, and comparisons among multiple groups were analyzed using one-way analysis of variance. Statistical significance was set at P < 0.05. All statistical analyses were carried out using GraphPad Prism 9.5 software (GraphPad Software, San Diego, CA, USA).

Results

Toxoplasma gondii infection promoting expression of miR-185 and inhibiting expression of ARAF

The levels of miR-185 and the mRNA levels of ARAF in mice and in PK-15 and 3D4/21 cells infected with T. gondii YZ-1 and RH strains, respectively, were determined by qPCR. The results showed that, compared with the groups with no infection, the levels of miR-185 in mouse tissues (Fig. 1a, b), PK-15 cells (Fig. 1c, d) and 3D4/21 cells (Fig. 1e, f) were significantly elevated (t = 3.820, P < 0.05), whereas the mRNA levels of ARAF in mouse tissues (Fig. 2a, b), PK-15 cells (Fig. 2c, d) and 3D4/21 cells (Fig. 2e, f) were significantly decreased (t = 8.563, P < 0.01). In contrast, the protein expression levels of ARAF in cells were detected using Western blot. The results showed that, compared with the groups without infection, the protein expression levels of ARAF in PK-15 (Fig. 2g, h) and 3D4/21 (Fig. 2i, j) cells were significantly decreased (t = 7.409, P < 0.05). These results suggest that T. gondii infection might promote the expression of miR-185 and inhibit the expression of ARAF both in vivo and in vitro, which occurred in both porcine macrophages (3D4/21) and epithelial cells (PK-15) infected with the Chinese I strain and RH strain of T. gondii, respectively.

Fig. 1
figure 1

Expression levels of miR-185 after Toxoplasma gondii infection. a Quantification of miR-185 in different organs of mice with T. gondii YZ-1 strain infection and without infection. b Quantification of miR-185 in different organs of mice with T. gondii RH strain infection and without infection. c Quantification of miR-185 in PK-15 (porcine kidney epithelial) cells with T. gondii YZ-1 strain infection and without infection. d Quantification of miR-185 in PK-15 cells with T. gondii RH strain infection and without infection. e Quantification of miR-185 in 3D4/21 cells (porcine alveolar macrophages) with T. gondii YZ-1 strain infection and without infection. f Quantification of miR-185 in 3D4/21 cells with T. gondii RH strain infection and without infection. Asterisks indicate a significant difference between controls (un-infected cells) and infected cells at *P < 0.05, **P < 0.01 and ***P < 0.001. miR-185, MicroRNA-185

Full size image
Fig. 2
figure 2

Expression levels of ARAF after T. gondii infection. a Quantification of ARAF in different organs of mice with T. gondii YZ-1 strain infection and without infection. b Quantification of ARAF in different organs of mice with T. gondii RH strain infection and without infection. c Quantification of ARAF in PK-15 (porcine kidney epithelial) cells with T. gondii YZ-1 strain infection and without infection. d Quantification of ARAF in PK-15 cells with T. gondii RH strain infection and without infection. e Quantification of ARAF in 3D4/21 cells (porcine alveolar macrophages) with T. gondii YZ-1 strain infection and without infection. f Quantification of ARAF in 3D4/21 cells with T. gondii RH strain infection and without infection. g Western blot detecting ARAF protein decrease in PK-15 cells after T. gondii YZ-1 strain infection; the bar graph indicates the relative protein expression of ARAF. h Western blot detecting ARAF protein decrease in PK-15 cells after T. gondii RH strain infection; the bar graph indicates the relative protein expression of ARAF. i Western blot detecting ARAF protein decrease in 3D4/21 cells after T. gondii YZ-1 strain infection; the bar graph indicates the relative protein expression of ARAF. j Western blot detecting ARAF protein decrease in 3D4/21 cells after T. gondii RH strain infection; the bar graph indicates the relative protein expression of ARAF. Asterisks indicate a significant difference between controls (un-infected cells) and infected cells at *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001

Full size image

MiR-185 mimic transfection inhibits expression of ARAF

To confirm that the downregulation of ARAF was achieved by miR-185, qPCR was performed to detect the levels of miR-185 and the mRNA levels of ARAF in PK-15 and 3D4/21 cells transfected with mimic. The results showed that, compared with the cells transfected with the mimic control, the levels of miR-185 in cells transfected with miR-185 mimic were significantly increased (Fig. 3a, b; t = 31.09, P < 0.0001), whereas the expression levels of ARAF mRNA in cells transfected with miR-185 mimic were significantly decreased (Fig. 3c, d; t = 9.092, P < 0.001). Western blot analysis further revealed that the protein expression levels of ARAF were also decreased after transfection (Fig. 3e, f). These results suggest that ARAF may be the target mRNA for miR-185 in PK-15 and 3D4/21 cells.

Fig. 3
figure 3

Expression levels of miR-185 and ARAF after miRNA transfection. a Quantification of miR-185 in PK-15 (porcine kidney epithelial) cells transfected with miR-185 mimic and mimic control. b Quantification of miR-185 in 3D4/21 cells (porcine alveolar macrophages) transfected with miR-185 mimic and mimic control. c Quantification of ARAF in PK-15 cells transfected with miR-185 mimic and mimic control. d Quantification of ARAF in 3D4/21 cells transfected with miR-185 mimic and mimic control. e Western blot detection of decrease in expression of ARAF protein after miRNA transfection in PK-15 cells; the bar graph indicates the relative protein expression of ARAF. f Western blot detection of decrease in ARAF protein after miRNA transfection in 3D4/21 cells; the bar graph indicates the relative protein expression of ARAF. Asterisks indicate a significant difference between cells transfected with mimic controls and cells transfected with miR-185 mimic at *P < 0.05, ***P < 0.001 and ****P < 0.0001

Full size image

MiR-185 directly targets ARAF

To further determine whether ARAF is a direct target gene of miR-185, the miR-185 target site was identified by an in silico miRNA target prediction search, followed by a dual luciferase reporter assay in PK-15 cells. The results showed that the binding site for miR-185 was composed of five continuous base pairs in the 3′ end of the ARAF gene (Fig. 4a). The double fluorescent reporter gene system showed that miR-185 mimics clearly inhibited luciferase activity in the psiCHECK2-ARAF WT group (t = 7.141, P < 0.01; Fig. 4b), while miR-185 mimics had no significant effect on luciferase activity in the NC and psiCHECK2-ARAF MUT groups (P > 0.05; Fig. 4b). These results suggest that ARAF is the target gene of miR-185. Therefore, miR-185 could target the mRNA of ARAF and negatively regulate the expression of ARAF.

Fig. 4
figure 4

The results of the dual-luciferase reporter assay. a The binding site between miR-185 and ARAF gene. b Luciferase assay of the reporter plasmids including the wild-type (WT) and mutant (MUT) ARAF 3′-untranslated region. NC, cells transfected with psiCHECK2, and co-transfected with miR-185 mimic or mimic control, respectively; ARAF WT, cells transfected with psiCHECK2-ARAF WT, and co-transfected with miR-185 mimic or mimic control, respectively; ARAF MUT, cells transfected with psiCHECK2-ARAF MUT, and co-transfected with miR-185 mimic or mimic control, respectively. Asterisks indicate a significant difference at **P < 0.01.

Full size image

MiR-185 regulating apoptosis of T. gondii-infected cells

In order to investigate whether miR-185 is involved in regulating apoptosis of T. gondii-infected cells, we examined the apoptotic rates of the PK-15 and 3D4/21 cells transfected with miR-185 mimic or miR-185 mimic control, when infected or not infected with T. gondii. The cell apoptosis rate was determined by flow cytometry using double labelling with Annexin V-FITC and propidium iodide. The results showed that following T. gondii infection, the apoptotic rates of PK-15 cells transfected with mimic control were significantly higher than those of cells transfected with miR-185 mimic (t = 23.40, P < 0.001; Fig. 5a). Similarly, the results showed that following T. gondii infection, the apoptotic rates of 3D4/21 cells transfected with mimic control were significantly higher than those of cells transfected with miR-185 mimic (t = 10.87, P < 0.001; Fig. 5b). In addition, compared with the group transfected with miR-185 mimic/T. gondii infection, the protein expression levels of cleaved caspase-3 protein in the group transfected with miR-185 mimic control/T. gondii infection were significantly elevated (t = 9.242, P < 0.01; Fig. 5). These results suggest that miR-185 overexpression could inhibit the apoptosis of cells induced by T. gondii.

Fig. 5
figure 5

Apoptosis rates of different cells with different treatments. The apoptosis of cells was analysed by flow cytometry following staining with Annexin V and PI. Dot plots depict the amounts of cells stained with Annexin V and/or PI; numbers in parentheses indicate percentages of cells in each quadrant from a representative experiment. Western blot detecting the expression levels of cleaved caspase-3 in different cells with different treatments. The bar graphs indicate the apoptosis rates and relative protein expression of cleaved caspase-3. All cells were separately infected with T. gondii YZ-1 strain and control cultivation. a Apoptosis rates and the expression levels of cleaved caspase-3 in PK-15 (porcine kidney epithelial) cells transfected with miR-185 mimic or mimic control. b Apoptosis rates and the expression levels of cleaved caspase-3 in 3D4/21 cells transfected with miR-185 mimic or mimic control. Asterisk indicates a significant difference at *P < 0.05, **P < 0.01 and ***P < 0.001. PI, Propidium iodide

Full size image

Knockout efficiency and overexpression of ARAF gene in the cell lines

To examine whether ARAF is involved in regulating apoptosis of T. gondii-infected cells, both PK-15 and 3D4/21 cell lines with stable ARAF knockout were successfully constructed. qPCR assays showed that, compared to control PK-15 and 3D4/21 cells, mRNA expression levels of ARAF in cells of both of the knockout lines (PK-15-KOARAF and 3D4/21-KOARAF) were significantly downregulated (t = 49.29, P < 0.001; Fig. 6a, b). Western blot analysis also revealed that expression levels of ARAF protein in PK-15-KOARAF and 3D4/21-KOARAF cells were significantly lower than those in PK-15 and 3D4/21 cells, respectively (t = 43.91, P < 0.001; Fig. 6c, d). In addition, the result of sequencing further demonstrated that the insertion of one base (adenine [A]) resulted in frameshift mutations of the ARAF gene (Fig. 6e). These results confirmed that the ARAF gene in both PK-15-KOARAF and 3D4/21-KOARAF cells was efficiently knocked out.

Fig. 6
figure 6

Knockout efficiency of cell lines with stable ARAF gene knockout. a Quantification of ARAF in PK-15-KOARAF cells and PK-15 cells. b Quantification of ARAF in 3D4/21-KoARAF cells and 3D4/21 cells. c Western blot detecting ARAF protein loss in PK-15-KOARAF cells; the bar graph indicates the relative protein expression of ARAF. d Western blot detecting ARAF protein loss in 3D4/21-KoARAF cells. e Mutation site of ARAF in PK-15-KOARAF and 3D4/21-KoARAF cells (adenine [A]); the bar graph indicates the relative protein expression of ARAF. Asterisks indicate a significant difference at ***P < 0.001 and ****P < 0.0001. 3D4/21-KoARAF, 3D4/21 cell line with stable ARAF gene knockout; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PK-15-KOARAF, PK-15 cell line with stable ARAF gene knockout

Full size image

The overexpression efficiency of the ARAF gene was detected by Western blot. The results showed that the expression levels of ARAF protein in PK-15 and PK-15-KOARAF cells transfected with the pcDNA3.1-Flag-ARAF vector were significantly higher than those in cells transfected with the pcDNA3.1-Flag vector (Fig. 7a). Similarly, the expression levels of ARAF protein in 3D4/21 and 3D4/21-KOARAF cells transfected with the pcDNA3.1-Flag-ARAF vector were significantly higher than those in cells transfected with the pcDNA3.1-Flag vector (Fig. 7b). These results further confirmed that the ARAF gene of PK-15-KOARAF and 3D4/21-KOARAF cells was efficiently knocked out in each of these cell lines and that the overexpression efficiency of pcDNA3.1-Flag-ARAF vector was sufficiently high to perform the subsequent experiment.

Fig. 7
figure 7

The overexpression efficiency of the different cell lines after transfection with the overexpression vector. The bar graphs indicate the relative protein expression of ARAF. a Western blot detecting ARAF protein overexpression in PK-15 and PK-15-KOARAF cells. b Western blot detecting ARAF protein overexpression in 3D4/21 and 3D4/21-KoARAF cells. Asterisks indicate a significant difference at **P < 0.01, ***P < 0.001 and ****P < 0.0001. 3D4/21-KoARAF, 3D4/21 cell line with stable ARAF gene knockout; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PK-15-KOARAF, PK-15 cell line with stable ARAF gene knockout

Full size image

Toxoplasma gondii infection regulating apoptosis of host cells through a miR-185/ARAF axis

To confirm whether T. gondii infection regulates apoptosis of host cells through a miR-185-ARAF axis, we determined the effect of ARAF knockout on apoptosis of T. gondii-infected cells. The apoptosis of cells was analszed by flow cytometry following staining with Annexin V-FITC and PI. The results showed that following T. gondii infection, the apoptotic rates of PK-15 and 3D4/21 cells were significantly higher than those of PK-15-KOARAF and 3D4/21-KOARAF cells (t = 16.24, P < 0.001; Fig. 8a, b), respectively. We further examined the effect of complementation of ARAF knockout using the overexpression vector on apoptosis of T. gondii-infected cells. The results showed that following T. gondii infection, the apoptotic rates of PK-15-KOARAF and 3D4/21-KOARAF cells transfected with pcDNA3.1-Flag-ARAF were significantly higher than those of PK-15-KOARAF and 3D4/21-KOARAF cells transfected with pcDNA3.1-Flag, respectively (t = 25.59, P < 0.0001; Fig. 8c, d). In addition, the results showed that following T. gondii infection, the expression levels of cleaved caspase-3 protein in PK-15-KOARAF and 3D4/21-KOARAF cells were significantly lower than those in PK-15 and 3D4/21 cells (t = 8.297, P < 0.01; Fig. 8a, b). Similarly, the results showed that following T. gondii infection, the expression levels of cleaved caspase-3 protein in PK-15-KOARAF and 3D4/21-KOARAF cells transfected with pcDNA3.1-Flag were significantly lower than those in PK-15-KOARAF and 3D4/21-KOARAF cells transfected with pcDNA3.1-Flag-ARAF, respectively (t = 5.397, P < 0.05; Fig. 8c, d). These results suggest that T. gondii infection could regulate apoptosis of host cells via the miR-185/ARAF axis.

Fig. 8
figure 8

Apoptosis rates of different cells with different treatments. The apoptosis of cells was analysed by flow cytometry following staining with Annexin V and PI. Dot plots depict the amounts of cells stained with Annexin V and/or PI; numbers in parentheses indicate percentages of cells in each quadrant from a representative experiment. Western blot detecting the expression levels of cleaved caspase-3 in different cells with different treatments. The bar graphs indicate the apoptosis rates and relative protein expression of cleaved caspase-3. All cells were separately infected with T. gondii YZ-1 strain and control cultivation. a Apoptosis rates and the expression levels of cleaved caspase-3 in PK-15 cells and PK-15-KoARAF cells. b Apoptosis rates and the expression levels of cleaved caspase-3 in 3D4/21 cells and 3D4/21-KoARAF cells. c Apoptosis rates and the expression levels of cleaved caspase-3 in PK-15-KOARAF cells transfected with the overexpression vector pcDNA3.1-Flag-ARAF or pcDNA3.1-Flag. d Apoptosis rates and the expression levels of cleaved caspase-3 of 3D4/21-KOARAF cells transfected with the overexpression vector pcDNA3.1-Flag-ARAF or pcDNA3.1-Flag. Asterisks indicate a significant difference at *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001. D4/21-KoARAF, 3D4/21 cell line with stable ARAF gene knockout; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PI, propidium iodide; PK-15-KOARAF, PK-15 cell line with stable ARAF gene knockout

Full size image

Discussion

In our previous studies, we found that infection by T. gondii Chinese I genotype YZ-1 strain induces the upregulation of miR-185 expression in spleen and brain tissues of piglets [14, 15]. In the present study, we further confirmed this upregulation of miR-185 expression in in vivo and in vitro experiments, further demonstrating that this T. gondii infection-induced upregulation was not related to the strain of T. gondii or the host cells. We first found that T. gondii infection resulted in the downregulation of ARAF gene expression and revealed a negative correlation between miR-185 and ARAF in cells infected with T. gondii. MiR-185 overexpression could inhibit the apoptosis of cells induced by T. gondii.

MiRNAs regulate gene expression by interacting with the 3′-untranslated regions (UTRs) of genes. Each miRNA usually controls up to several hundred target mRNAs, while one mRNA target can be synergistically regulated by multiple miRNAs [29,30,31]. To date, > 80 genes and/or pathways that are targeted by miR-185 have been identified, some of which were found to be involved in regulating apoptosis of cell lines, including protein kinase b (Akt), AKT serine/threonine kinase 1 (AKT1), cell division cycle 42 (CDC42), cyclin D2 (CCND2), cyclin dependent kinase 4 (CDK4), cyclin dependent kinase 6 (CDK6), cathepsin D (CTSD), high mobility group AT-hook 2 (HMGA2) forkhead box D3 (FOXD3), ras-related gtp-binding protein 14 (RAB14), ras homolog family member A (RHOA), microphthalmia transcription factor (SMAD7), tripartite motif containing 29 (TRIM29), Akt/caspase 9 (CASP-9) pathway, Akt/nuclear factor kappa-B (NF-κB) pathway and Wnt/β-catenin pathway [18, 20, 32]. In the present study, miR-185 mimic transfection could inhibit the expression of ARAF. The dual luciferase reporter gene assay showed that the 3′-UTR region of ARAF could bind specifically to miR-185, indicating that ARAF is a novel target gene of miR-185.

Previous studies have shown that ARAF plays an important role in apoptosis, tumourigenesis and resistance to Raf inhibitors [33,34,35]. ARAF dysregulation is closely associated with the initiation and progression of neoplastic diseases [36]. ARAF has a strong binding ability to mammalian sterile 20-like kinase 2 (MST2) and can block the Hippo signaling pathway mediated by MST2 phosphorylation [34]. Independent of kinase activity, ARAF binds to MST2, thereby efficiently inhibiting apoptosis [34, 37]. In the present study, we found that ARAF knockout inhibited the apoptosis induced by T. gondii and that ARAF overexpression in knockout cells reversed these regulatory effects. These observations suggest that ARAF participates in regulation of the apoptotic process induced by T. gondii infection. However, the downstream molecule regulated by ARAF need further study.

MiR-185 participates in the regulation of apoptosis by targeting different genes or signaling pathways in cancer cell lines [18, 38, 39]. For example, miR-185 was found to induce apoptosis and autophagy in hepatocellular carcinoma cells by targeting different genes in the Akt signaling pathway, including AKT1, rapamycin-insensitive companion of Mtor (RICTOR) and ras homolog enriched in brain (RHEB) [40]; miR-185 directly targeted the Na + /H + exchanger isoform 1 (NHE-1) gene to inhibit endoplasmic reticulum (ER) stress-induced apoptosis for the purpose of cardiac protection [41]; miR-185 overexpression inhibited autophagy and apoptosis in dopaminergic cells from Parkinson patients by regulating the AMP-activated protein kinase (AMPK)/mechanistic target of rapamycin kinase (mTOR) signaling pathway [42]. In the present study, we observed that: (i) the upregulation of miR-185 is a specific response to T. gondii infection both in in vivo and in vitro, and in both somatic cells (PK-15 cell) and immune cells (3D4/21 cell); (ii) the Toxoplasma-induced increase of miR-185 expression is associated with a downregulation of ARAF and an increased apoptosis rate; and (iii) that T. gondii infection resulted in an increase of the cleaved caspase-3 protein expression. These results indicate that T. gondii infection could regulate apoptosis of host cells via the miR-185/ARAF axis.

Despite many studies having shown that T. gondii manipulates multiple pathways, including NF-κB, mitogen-activated protein kinase (MAPKinase), c-Jun-terminal kinases (JNKinase) and phosphatidylinositol 3 kinase (PI3K)/Akt, to regulate cell apoptosis [43], only a few host miRNAs have been confirmed to be involved in apoptosis pathways elaborated by T. gondii. Cai et al. [44] found that in human macrophages following T. gondii infection, the activated STAT3 binds to the promoter of the miRNA (miR-30c-1, miR-125b-2, miR-23b-27b-24–1 and miR-17~92 cluster) genes, which leads to increased miRNA expression and increased apoptosis of host cells. Further research showed that STAT3 mediates a prosurvival pathway by upregulating the miR-17–92 cluster expression that in turn targets BCL2-like 11 (Bim), leading to the survival of host cells with Toxoplasma infection [45]. Hence, the miR-185/ARAF axis represents an additional strategy by which T. gondii counteracts host-cell apoptosis in order to maintain survival and reproduce in the host cells.

In summary, our results reveal that the upregulation of miR-185 is a specific response to T. gondii infection both in in vivo and in vitro, and in porcine somatic cells (PK-15 cell line) and alveolar macrophages (3D4/21 cell line). ARAF is a novel target gene of miR-185. Toxoplasma gondii infection could regulate apoptosis of host cells via miR-185/ARAF axis, which represents an additional strategy by which T. gondii counteracts host-cell apoptosis in order to maintain survival and breed in the host cells.

Availability of data and materials

All data and materials of the experiments described here are included in this published article and its additional files.

Abbreviations

T. gondii :

Toxoplasma gondii

MiRNA:

MicroRNA

ARAF:

A-rapidly accelerated fibrosarcoma

QPCR :

Quantitative real-time PCR

SDS-PAGE :

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis

CL-caspase3 :

Cleaved caspase-3

SgRNA :

Single guide RNA

References

  1. Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139:1375–424.

    CAS  PubMed  Google Scholar 

  2. Dubey JP, Cerqueira-Cézar CK, Murata FHA, Kwok OCH, Hill D, Yang Y, et al. All about Toxoplasma gondii infections in pigs: 2009–2020. Vet Parasitol. 2020;288:109185.

    CAS  PubMed  Google Scholar 

  3. Dong H, Su R, Lu Y, Wang M, Liu J, Jian F, et al. Prevalence, risk factors, and genotypes of Toxoplasma gondii in food animals and humans (2000–2017) from China. Front Microbiol. 2018;9:2108.

    PubMed  PubMed Central  Google Scholar 

  4. Almeria S, Dubey JP. Foodborne transmission of Toxoplasma gondii infection in the last decade. An overview. Res Vet Sci. 2021;135:371–85.

    CAS  PubMed  Google Scholar 

  5. Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009;39:895–901.

    PubMed  PubMed Central  Google Scholar 

  6. Dubey JP. Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned. Parasit Vectors. 2021;14:263.

    PubMed  PubMed Central  Google Scholar 

  7. Dubey JP. Toxoplasmosis in sheep–the last 20 years. Vet Parasitol. 2009;163:1–14.

    CAS  PubMed  Google Scholar 

  8. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001;294:862–4.

    CAS  PubMed  Google Scholar 

  9. Malla RR, Kumari S, Gavara MM, Badana AK, Gugalavath S, Kumar DKG, et al. A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer. Biophys Rev. 2019;11:227–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Xu M, Zhou D, Nisbet AJ, Huang S, Fan Y, Zhu X. Characterization of mouse brain microRNAs after infection with cyst-forming Toxoplasma gondii. Parasit Vectors. 2013;6:154.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Cong W, Zhang X-X, He J-J, Li F-C, Elsheikha HM, Zhu X-Q. Global miRNA expression profiling of domestic cat livers following acute Toxoplasma gondii infection. Oncotarget. 2017;8:25599–611.

    PubMed  PubMed Central  Google Scholar 

  12. de Faria Junior GM, Murata FHA, Lorenzi HA, Castro BBP, Assoni LCP, Ayo CM, et al. The role of microRNAs in the infection by T. gondii in humans. Front Cell Infect Microbiol. 2021;11:670548.

    PubMed  PubMed Central  Google Scholar 

  13. Shapira S, Speirs K, Gerstein A, Caamano J, Hunter CA. Suppression of NF-kappaB activation by infection with Toxoplasma gondii. J Infect Dis. 2002;185:S66-72.

    CAS  PubMed  Google Scholar 

  14. Hou Z, Zhang H, Xu K, Zhu S, Wang L, Su D, et al. Cluster analysis of splenocyte microRNAs in the pig reveals key signal regulators of immunomodulation in the host during acute and chronic Toxoplasma gondii infection. Parasit Vectors. 2022;15:58.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Hou Z, Wang L, Su D, Cai W, Zhu Y, Liu D, et al. Global microRNAs expression profile analysis reveals possible regulatory mechanisms of brain injury induced by Toxoplasma gondii infection. Front Neurosci. 2022;16:827570.

    PubMed  PubMed Central  Google Scholar 

  16. de la Morena MT, Eitson JL, Dozmorov IM, Belkaya S, Hoover AR, Anguiano E, et al. Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome. Clin Immunol. 2013;147:11–22.

    PubMed  PubMed Central  Google Scholar 

  17. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007;370:1443–52.

    CAS  PubMed  Google Scholar 

  18. Babaeenezhad E, Naghibalhossaini F, Rajabibazl M, Jangravi Z, Hadipour Moradi F, Fattahi MD, et al. The roles of microRNA miR-185 in digestive tract cancers. Noncoding RNA. 2022;8:67.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Chang H, Wang Y, Liu H, Nan X, Wong S, Peng S, et al. Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis. Cell Death Dis. 2017;8:3221.

    PubMed  PubMed Central  Google Scholar 

  20. Cui Q, Xing J, Yu M, Wang Y, Xu J, Gu Y, et al. Mmu-miR-185 depletion promotes osteogenic differentiation and suppresses bone loss in osteoporosis through the Bgn-mediated BMP/Smad pathway. Cell Death Dis. 2019;10:172.

    PubMed  PubMed Central  Google Scholar 

  21. An S, Yang Y, Ward R, Liu Y, Guo X-X, Xu T-R. A-Raf: a new star of the family of raf kinases. Crit Rev Biochem Mol Biol. 2015;50:520–31.

    CAS  PubMed  Google Scholar 

  22. Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 2006;24:21–44.

    CAS  PubMed  Google Scholar 

  23. Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, et al. Raf family kinases: old dogs have learned new tricks. Genes Cancer. 2011;2:232–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Rauch J, Vandamme D, Mack B, McCann B, Volinsky N, Blanco A, et al. Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation. Cell Death Differ. 2016;23:1283–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Zhang X, Guo H, Han B, Zhang X, Huang Y, Yang Y, et al. Revealing A-Raf functions through its interactome. Biochim Biophys Acta Proteins Proteom. 2018;1866:849–56.

    CAS  PubMed  Google Scholar 

  26. Hou Z, Zhou Y, Liu D, Su S, Zhao Z, Xu J, et al. Genotyping and virulence analysis of Toxoplasma gondii isolates from a dead human fetus and dead pigs in Jiangsu province, Eastern China. Acta Parasitol. 2018;63:397–411.

    CAS  PubMed  Google Scholar 

  27. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989;77:51–9.

    CAS  PubMed  Google Scholar 

  28. Xu K, Zhang H, Sun Q, Lin Y, Zhu Y. Eukaryotic expression of porcine ARAF gene and its regulatory role on apoptosis of PK15 cells. Chin Vet Sci. 2022;2022:1456–64.

  29. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.

    CAS  PubMed  Google Scholar 

  30. Didiano D, Hobert O. Molecular architecture of a miRNA-regulated 3′ UTR. RNA. 2008;14:1297–317.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Drew LJ, Crabtree GW, Markx S, Stark KL, Chaverneff F, Xu B, et al. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int J Dev Neurosci. 2011;29:259–81.

    CAS  PubMed  Google Scholar 

  32. Yao C-J, Lv Y, Zhang C-J, Jin J-X, Xu L-H, Jiang J, et al. MicroRNA-185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt/β-catenin axis: in an animal experiment. Biochem Biophys Res Commun. 2018;501:55–63.

    CAS  PubMed  Google Scholar 

  33. Rauch J, Kolch W. Spatial regulation of ARAF controls the MST2-Hippo pathway. Small GTPases. 2019;10:243–8.

    CAS  PubMed  Google Scholar 

  34. Rauch J, O’Neill E, Mack B, Matthias C, Munz M, Kolch W, et al. Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription. Cancer Res. 2010;70:1679–88.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Yen I, Shanahan F, Lee J, Hong YS, Shin SJ, Moore AR, et al. ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma. Nature. 2021;594:418–23.

    CAS  PubMed  Google Scholar 

  36. Kemps PG, Zondag TCE, Arnardóttir HB, Solleveld-Westerink N, Borst J, Steenwijk EC, et al. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study. Blood Adv. 2023;7:664–79.

    CAS  PubMed  Google Scholar 

  37. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D, et al. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell. 2007;27:962–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Niu Y, Tang G. miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma. Oncol Lett. 2019;17:5087–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Fan L, Tan B, Li Y, Zhao Q, Yuan H, Liu Y, et al. Upregulation of miR-185 promotes apoptosis of the human gastric cancer cell line MGC803. Mol Med Rep. 2018;17:3115–22.

    CAS  PubMed  Google Scholar 

  40. Zhou L, Liu S, Han M, Feng S, Liang J, Li Z, et al. MicroRNA-185 induces potent autophagy via AKT signaling in hepatocellular carcinoma. Tumour Biol. 2017;39:1010428317694313.

    PubMed  Google Scholar 

  41. Kim JO, Kwon EJ, Song DW, Lee JS, Kim DH. miR-185 inhibits endoplasmic reticulum stress-induced apoptosis by targeting Na+/H+ exchanger-1 in the heart. BMB Rep. 2016;49:208–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Wen Z, Zhang J, Tang P, Tu N, Wang K, Wu G. Overexpression of miR-185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson’s disease. Mol Med Rep. 2018;17:131–7.

    CAS  PubMed  Google Scholar 

  43. Mammari N, Halabi MA, Yaacoub S, Chlala H, Dardé M-L, Courtioux B. Toxoplasma gondii modulates the host cell responses: an overview of apoptosis pathways. Biomed Res Int. 2019;2019:6152489.

    PubMed  PubMed Central  Google Scholar 

  44. Cai Y, Chen H, Jin L, You Y, Shen J. STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage. Parasit Vectors. 2013;6:356.

    PubMed  PubMed Central  Google Scholar 

  45. Cai Y, Chen H, Mo X, Tang Y, Xu X, Zhang A, et al. Toxoplasma gondii inhibits apoptosis via a novel STAT3-miR-17-92-Bim pathway in macrophages. Cell Signal. 2014;26:1204–12.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We especially thank the Testing Center of Yangzhou University for providing technical support.

Funding

This study was supported by the National Natural Science Foundation of China (No. 32002303 to ZH), the China Postdoctoral Science Foundation (No. 2020M671615 to ZH), the Basic Research Program of Jiangsu Province (No. BK20190885 to ZH), the International Research Laboratory of Prevention and Control of Important Animal Infectious Diseases and Zoonotic Diseases of Jiangsu Higher Education Institutions (No. 6 to ZH), Undergraduate Scientific Research Innovation Funds of Yangzhou University (No. X20220678 to YZ), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Taizhou Project of Scientific Research for Talent Cultivation (No. RCPY201929 to FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Author notes

  1. Dingzeyang Su and Shifan Zhu contributed equally to this work.

Authors and Affiliations

  1. College of Veterinary Medicine, Yangzhou University, 12 East Wenhui Road, Yangzhou, 225009, Jiangsu, People’s Republic of China

    Dingzeyang Su, Shifan Zhu, Zhaofeng Hou, Kangzhi Xu, Fan Xu, Yuyang Zhu, Dandan Liu, Jinjun Xu & Jianping Tao

  2. Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou, 225009, People’s Republic of China

    Dingzeyang Su, Shifan Zhu, Zhaofeng Hou, Kangzhi Xu, Fan Xu, Yuyang Zhu, Dandan Liu, Jinjun Xu & Jianping Tao

  3. International Research Laboratory of Prevention and Control of Important Animal Infectious Diseases and Zoonotic Diseases of Jiangsu Higher Education Institutions, Yangzhou University, Yangzhou, 225009, People’s Republic of China

    Dingzeyang Su, Shifan Zhu, Zhaofeng Hou, Kangzhi Xu, Fan Xu, Yuyang Zhu, Dandan Liu, Jinjun Xu & Jianping Tao

  4. Jiangsu Agri-Animal Husbandry Vocational College, Taizhou, 225300, People’s Republic of China

    Fuxing Hao

Authors
  1. Dingzeyang Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shifan Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhaofeng Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fuxing Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kangzhi Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuyang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dandan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jinjun Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jianping Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZFH, JPT, DZYS and FXH conceived, designed, and supervised the experiments. DZYS, SFZ, KZX, FX and YYZ performed the experiments and analyzed the data. DZYS and JPT wrote the paper. ZFH, DDL and JJX contributed to the revision of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zhaofeng Hou or Jianping Tao.

Ethics declarations

Ethics approval and consent to participate

All animals were handled in strict accordance with good animal practice as defined by the Animal Ethics Procedures and Guidelines of the People’s Republic of China. The study protocol was approved by the Animal Care and Use Committee of the College of Veterinary Medicine, Yangzhou University (Approval ID: SCXK [Su] 2021-0013).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Su, D., Zhu, S., Hou, Z. et al. Toxoplasma gondii infection regulates apoptosis of host cells via miR-185/ARAF axis. Parasites Vectors 16, 371 (2023). https://doi.org/10.1186/s13071-023-05991-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-023-05991-y

Keywords

Parasites & Vectors

ISSN: 1756-3305

Contact us